glp-1 drugs pharmaceutical companies 2025 How GLP-1s Are Showing Up at CES 2025 GLP-1 Market Trends and Global
Description
A 68-week clinical trial of Wegovy was conducted with 1,961 adults
Wegovy is the first once-weekly GLP-1 receptor agonist approved as a weight loss medication for people under the age of 18
CMAJ, 196 (43), E1413
doi: 10.1210/en.2007-1292 46 KimJYLeeSKJoKJSongDYLimDMParkKYet al
